Literature DB >> 12940521

Endocrine alterations in the aging male.

Martin W Elmlinger1, Thomas Dengler, Christoph Weinstock, Werner Kuehnel.   

Abstract

The recent increase in the elderly population, current health trends and awareness of age-related changes in the male endocrine system, have led to discussions about the role of the hormonal changes in the aging process in males. Better prevention and treatment of suboptimal health status and age-related diseases in aging men are based on an improved understanding of aging, particularly of the significance of age-associated hormonal changes. The aims of this study were 1) to evaluate the age dependence of the serum concentrations of the following important hormonal parameters in adult males using the IMMULITE 1 automated assay system (DPC, Los Angeles): testosterone, dehydro-epiandrosterone sulfate (DHEAS), estradiol (E2), sex hormone binding globulin (SHBG), lutropin (LH), follitropin (FSH), cortisol, prolactin, thyroid stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4) and the growth hormone-dependent parameters insulin-like growth factor (IGF-I) and IGF-binding protein-3 (IGFBP-3) and 2) to derive the following parameters: calculated free testosterone (cFT), ratio of calculated free testosterone to total testosterone (% cFT) and free androgen index (FAI). We found a significant decrease between the 21-30-year age group and the > 70-year age group for total testosterone (-42.4%), FAI (-65.5%), cFT (-60.0%), % cFT (-30.0%), DHEAS (-71.9%), E2 (-35.4%), TSH (-23.6%), IGF-I (-40.3%) and IGFBP-3 (-26.5%). Since the decreases in the FAI and cFT were greater than that of total testosterone and because these derived parameters reflect the biologically active fraction of testosterone, FAI and cFT are better markers for androgen deficiency in males. In contrast, a significant increase with age was observed for SHBG (+61.2%), LH (+40.0%), FSH (+98.3%) and cortisol (+54.2%). No significant alterations with age were observed for prolactin, fT3 and fT4. The study demonstrates that determining complete profiles of the androgenic, gonadotropic, adrenocortical, thyroid, pituitary and growth hormone/IGF endocrine axes in middle-aged and elderly men may be helpful in obtaining a correct clinical diagnosis for various hormonal disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940521     DOI: 10.1515/CCLM.2003.142

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.

Authors:  Maria Wichers-Rother; Andreas Grigull; Piotr Sokolowski; Birgit Stoffel-Wagner; Wolfgang Köhler
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

2.  Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.

Authors:  E O Kehinde; A O Akanji; A Memon; A A Bashir; A S Daar; K A Al-Awadi; T Fatinikun
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Lrriq1 is an essential factor for fertility by suppressing apoptosis.

Authors:  Mayu Fukutomi; Chiharu Uedono; Aki Fujii; Youichi Sato
Journal:  J Assist Reprod Genet       Date:  2022-09-21       Impact factor: 3.357

4.  Ageing-induced alterations in lipid/phospholipid profiles of rat brain and liver mitochondria: implications for mitochondrial energy-linked functions.

Authors:  Hiren R Modi; Surendra S Katyare; Minal A Patel
Journal:  J Membr Biol       Date:  2007-12-21       Impact factor: 1.843

5.  Insulin-like Growth Factor 1 and Prolactin Levels in Chimpanzees (Pan troglodytes) Across the Lifespan.

Authors:  Anat Ben-Shlomo; Sandra M McLachlan; Jennifer Hwe; Holly Aliesky; Dana Hasselschwert; James Mirocha; Shlomo Melmed
Journal:  J Endocr Soc       Date:  2021-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.